Article Details

Verve Therapeutics Founded to Protect Against Heart Disease Launches with $58.5 Million in ...

Retrieved on: 2019-05-06 17:56:15

Tags for this article:

Click the tags to see associated articles and topics

Verve Therapeutics Founded to Protect Against Heart Disease Launches with $58.5 Million in .... View article details on hiswai:

Excerpt

<div>The $58.5 million Series A financing was led by GV (formerly <b>Google Ventures</b>), with participation from ARCH Venture Partners, F-Prime Capital, and ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up